A Feasibility Trial using Molecular-Guided Therapy for the Treatment of Patients with Refractory or Recurrent Neuroblastoma
Saulnier Sholler G, Bergendahl G, Vander Werff A, Dutta A, Ferguson W, Roberts W, Eslin D, Kraveka J, Kaplan J, Mitchell D, Parikh N, Neville K, Ashikaga T, Bond J,[...]
A Phase 1 Trial of DFMO as a Single Agent and in Combination with Etoposide in Patients with Refractory or Recurrent Neuroblastoma
Saulnier Sholler G, Gerner E, Bergendahl G, LaFleur B, VanderWerff A, Ashilkaga T, Ferguson W, Roberts W, Wada R, Eslin D, KravekaJ, Kaplan J, Mitchell D, Parikh N, Neville K, Sender[...]
Nifurtimox and radiation for treating neuroblastoma: a pre-clinical study
Eslin D, Lee C, Saulnier Sholler G, Sankpal U, Sutphin R, and Basha R. Nifurtimox and radiation for treating neuroblastoma: a pre-clinical study. American Association for Cancer Research Annual Meeting April 2013.[...]
Targeting both ornithine decarboxylase and polyamine transport inhibits tumor growth in neuroblastoma
Kendzicky A, Zhao P, Samal K, Yco L, McClung H, Gerner E, Bachmann A, Saulnier Sholler G. Targeting both ornithine decarboxylase and polyamine transport inhibits tumor growth in neuroblastoma. American Association for[...]
YM155 Inhibits Survivin-mediated survival, migration, and tumor growth in neuroblastoma
McClung HM, Zhao P, Eckardt A, Smith L, Saulnier Sholler G. YM155 Inhibits Survivin-mediated survival, migration, and tumor growth in neuroblastoma. American Association for Cancer Research Annual Meeting April 2013. Washington, DC.
AMXT-1501, a novel polyamine transport inhibitor, synergizes with DFMO in inhibiting neuroblastoma cell proliferation by targeting both ornithine decarboxylase and polyamine transport
Samal K, Zhao P, McClung H, Gerner EW, Bachmann AS, Saulnier Sholler G. AMXT-1501, a novel polyamine transport inhibitor, synergizes with DFMO in inhibiting neuroblastoma cell proliferation by targeting both ornithine[...]
YM155 Inhibits survivin-mediated survival, migration, and tumor growth in neuroblastoma
McClung HM, Zhao P, Smith L, Saulnier Sholler G. YM155 Inhibits survivin-mediated survival, migration, and tumor growth in neuroblastoma. Advances in Neuroblastoma Research (ANR) annual meeting June 2012, Toronto, ON.
A Pilot Trial Testing the Feasibility of Using Molecular-Guided Therapy in Patients with Recurrent Neuroblastoma. Journal of Cancer Therapy
Saulnier Sholler G, Ferguson W, Bergendahl G, Currier E, Lenox SR, Bond J, Slavik M, Roberts W, Mitchell D, Eslin D, Kraveka J, Kaplan J, Parikh N, Malempati S, Hanna [...]
Side population analysis and gene expression profiling identify Notch pathway genes in neuroblastoma
Cecilia M, Mendonça F, Newton T, Saulnier Sholler G, and Roberts S. Side population analysis and gene expression profiling identify Notch pathway genes in neuroblastoma April 2012 AACR Annual Meeting, Chicago, IL
Single tumor imaging with multiple antibodies targeting different antigens. Biotechniques
Sun Y, Shukla G, Pero SC, Currier E, Saulnier Sholler G, Krag D. Single tumor imaging with multiple antibodies targeting different antigens. Biotechniques. 2012 Apr;0(0):1-3.